| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 1.2e-05 | 1 |